Fig. 2
From: Extracorporeal shock waves effectively suppress colorectal cancer proliferation and growth
60 mJ ESV suppresses the growth of HT29-derived xenografts. A Body weights of control (CON) and 60 mJ mice (n = 4). B–C Serum alanine aminotransferase (ALT) and creatinine (Cr) in plasma (n = 4). D Relative tumour volumes at day 0, day 3, day 6, day 9, day 12 and day 15 after the first ESV treatment (n = 4). E Images of tumours at the end of the experiment (n = 4). F Mouse livers of 60 mJ ESV group at the end of the experiment (n = 2). Representative pictures of H&E staining of paraffin-embedded liver sections (Scale: 100 μm). Data are presented as means ± SD of three independent experiments. Statistical significance was determined using one-way ANOVA with Tukey’s test. *p < 0.05.
